On July 23, 2008 I wrote an article on deep vein thrombosis (DVT), a hidden danger for men with prostate cancer. Studies show more than 90 percent of patients with cancer may experience an increase in the blood’s clotting activity, which can lead to a Deep Vein Thrombosis, or DVTs. DVTs can be a life [...]
As I have discussed many times there is very little consensus about standard definitions or treatments for prostate cancer. Go to any doctor who supplies primary treatment and ask about their erectile or incontinence rates. Then ask them how they define those rates. The results will be all over the place with no consistency among [...]
I extracted the following from a news release published today about a new potential vaccine therapy for advanced prostate cancer. My reason for republishing it is not for the informational value, but is to share my feelings about the sorry state of prostate cancer treatment. Please read the press release and then my comments that [...]
At 9 am this morning, Dendreon Corporation (Nasdaq: DNDN) announced the long awaited interim analysis of the Phase 3, randomized, double-blind, placebo-controlled IMPACT (Immunotherapy for Prostate AdenoCarcinoma Treatment, also known as D9902B). The clinical trial is designed to assess the safety and efficacy of the investigational active cellular immunotherapy Provenge® (sipuleucel-T) in men with metastatic [...]
The Department of Urology at the Hospital São João in Portugal examined the intermediate-term outcome (up to 4 years) of a bone-anchored perineal sling (InVance(TM), produced by American Medical Systems, Minnetonka, MN, USA) in men with stress urinary incontinence (SUI) after prostate surgery. Sixty two men with SUI after prostate cancer surgery were given the [...]